Kits Eyecare Reports Preliminary Q1 Revenues Of $46.6 Million
Kits Eyecare (TSX: KITS) has released preliminary data on its first quarter results this morning, indicating that it continues to see substantial growth on a year over year basis.
Revenue in the first quarter is said to have grown to $46.6 million, a 34% improvement over the $34.8 million in revenue reported in the first quarter of 2024.
Adjusted EBITDA meanwhile is said to have hit record levels, and is expected to have exceeded 7.0% of revenue. The figure implies Adjusted EBITDA of approximately $3.3 million, which compares to the year ago period that posted just $0.6 million in Adjusted EBITDA for the quarter. The company had previously guided to Adjusted EBITDA in a range of 6% to 8% of revenue.
The company meanwhile is reporting that it ended the quarter with $17.5 million in cash on hand.
Full financial results for Q1 are scheduled to be released in early May.
Kits Eyecare last traded at $10.47 on the TSX.
Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
